All In Biotech

Drug Trial Radar · NCT02261493

A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides

Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)

Last checked: Nov 20, 2026Latest source record: Jul 25, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 787 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

787

Actual

Start

Oct 27, 2014

Primary completion

Jun 3, 2015

Study completion Apr 20, 2016

Sponsor

Lead sponsor
AllerganAbbVie (ABBV)
Sponsor type
Industry
First posted
Oct 10, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a safety and efficacy study of onabotulinumtoxinA in subjects with upper facial rhytides (forehead lines, glabellar lines, lateral canthal lines \[crow's feet lines\]).

Conditions

  • Facial Rhytides
  • Glabellar Rhytides

Interventions

  • OnabotulinumtoxinABiological

    OnabotulinumtoxinA injected into the protocol-specified areas. Subjects will receive at least 1 and up to 3 treatments.

  • Normal SalineDrug

    Placebo (normal saline) injected into the protocol-specified areas on Day 1.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Subjects With ≥2-Grade Improvement From Baseline on Both the Investigator's and Subject's Facial Wrinkle Scale (FWS) Ratings of Forehead Line Severity at Maximum Eyebrow ElevationTime frame: Baseline, Day 30

Locations

24 sites in 4 countries. Site status is shown where the registry gives one.

  • The Petrus Center for Aesthetic

    Little Rock, Arkansas

  • Westside Aesthetics

    Los Angeles, California

  • Eye Research Foundation

    Newport Beach, California

  • Steve Yoelin, MD Medical Associates, Inc.

    Newport Beach, California

  • Baumann Cosmetic & Research Institute

    Miami, Florida

  • Saint Louis University

    St Louis, Missouri

  • The Center For Dermatology Cosmetic and Laser Surgery

    Mount Kisco, New York

  • Tennessee Clinical Research Center

    Nashville, Tennessee

  • The Center for Skin Research

    Houston, Texas

  • Premier Clinical Research

    Spokane, Washington

  • Aalst Dermatology Clinic

    Aalst, Belgium

  • UZ Brussel

    Jette, Belgium

  • Medical Skin Care - Sint-Truiden

    Limbourg, Belgium

  • Rosenpark Research

    Darmstadt, Germany

  • Hautzentrum Koeln (Cologne Dermatology)

    Köln Nordrhein-Westfalen, Germany

  • Hautok und hautok-cosmetics

    München, Germany

  • Praxisgemeinschaft Theatiner46

    München, Germany

  • Hautzentrum am Starnberger See GmbH

    Starnberg, Germany

  • CentroDerm Study Center

    Wuppertal, Germany

  • Shakespeare House Health Centre, General Practice

    Basingstoke, United Kingdom

  • Medizen Clinic

    Birmingham, United Kingdom

  • The Bosham Clinic

    Chichester, United Kingdom

  • Waverlery Medical Practice

    Coatbridge, United Kingdom

  • The Gatehouse

    Whitegate, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.